Prevention by the 5-HT3 receptor antagonist, ondansetron, of morphine-dependence and tolerance in the rat

British Journal of Pharmacology

Volumn 118, Issue 4, 1996, Pages 1044-1050

  Hui, Siu Chun G ^a   Sevilla, Elenita L ^b   Ogle, Clive W ^c  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b Cebu Institute of Medicine   (Philippines)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cyproheptadine; Morphine dependence; Morphine tolerance; Ondansetron

Indexed keywords

CYPROHEPTADINE; MORPHINE; NALOXONE; ONDANSETRON; SEROTONIN 2 ANTAGONIST; SEROTONIN 3 ANTAGONIST; NARCOTIC ANTAGONIST; SEROTONIN ANTAGONIST;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; MALE; MORPHINE ADDICTION; MORPHINE TOLERANCE; NONHUMAN; PRIORITY JOURNAL; RAT; TAIL FLICK TEST; WITHDRAWAL SYNDROME; ANIMAL; SPRAGUE DAWLEY RAT;

ANIMALS; CYPROHEPTADINE; MALE; MORPHINE DEPENDENCE; NALOXONE; NARCOTIC ANTAGONISTS; ONDANSETRON; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN ANTAGONISTS;

EID: 0029658979     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15504.x     Document Type: Article

References (26)

1. 3 receptor-mediated antinociception: possible release of GABA. J. Neurosci., 11, 1881-1886.
2. BADAWY, A.A.-B., EVANS, C.M. & EVANS, M. (1982). Production of tolerance and physical dependence in the rat by simple administration of morphine in drinking water. Br. J. Pharmacol., 75, 485-491.
3. 3 receptor releases dopamine from rat striatal slice. Eur. J. Pharmacol., 155, 349-350.
4. BOZARTH, A. (1987). Ventral tegmental reward system. In Brain Reward Systems and Abuse. ed. Engel, J. & Oreland, L. pp. 1-17. New York: Raven Press.
5. BOZARTH, M. A. & WISE, R. A. (1981). Heroin reward is dependent on a dopaminergic substrate. Life Sci., 29, 1881-1886.
6. BRADLEY, P.B., ENGEL, G., FENIUK, W., FOZARD, J.R., HUMPHREY, P.P.A., MIDDLEMISS, D.N., MYLECHARANE, E.J., RICHARDSON, B.P. & SAXENA, P.R. (1986). Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine. Neuropharmacology, 25, 563-576.
7. 3 receptors. Br. J. Pharmacol., 94, 397-412.
8. 3 receptor antagonists block morphine- and nicotine-induced place preference conditioning. Eur. J. Pharmacol., 151, 159-160.
9. COLLIER, H.O.J., FRANCIS, D.L., HENDERSON, G. & SCHNEIDER, C. (1974). Quasi morphine-abstinence syndrome. Nature, 249, 471-473.
10. 3 receptor antagonist, GR 3802F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain. Br. J. Pharmacol., 92, 881-894.
11. COSTALL, B., JONES, B.J., KELLY, M.E., NAYLOR, R.J., ONAIVI, E.S. & TYERS, M.B. (1989). The effects of ondansetron (GR 38032F) in rats and mice treated subchronically with diazepam. Pharmacol. Biochem. Behav., 34, 769-778.
12. COSTALL, B., JONES, B.J., KELLY, M.E., NAYLOR, R.J., ONAIVI, E.S. & TYERS, M.B. (1990a). Ondansetron inhibits a behavioural consequence of withdrawal from drugs of abuse. Pharmacol. Biochem. Behav., 36, 339-344.
13. COSTALL, B., JONES, B.J., KELLY, M.E., NAYLOR, R.J., ONAIVI, E.S. & TYERS, M.B. (1990b). Sites of action of ondansetron to inhibit withdrawal from drugs of abuse. Pharmacol. Biochem. Behav., 36, 97-104.
14. DAI, S., HUI, S.-C.G. & OGLE, C.W. (1984). Morphine preference in rats previously morphine-dependent. Pharmacol. Res. Commun., 16, 495-512.
15. DI CHIARA, G. & IMPERATO, A. (1988). Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl. Acad. Sci. U.S.A., 85, 5274-5278.
16. 3 receptor antagonist, GR 38032F, on responses to injection of a neurokinin agonist into the ventral tegmental area of the rat brain. Eur. J. Pharmacol., 138, 303-305.
17. 3 receptor antagonists MDL 72222 and ondansetron on morphine place conditioning. Psychopharmacology, 106, 315-320.
18. 3 antagonists reduce morphine self-administration in rats. Br. J. Pharmacol., 110, 1341-1446.
19. 3 receptors in rat brain using radioligand binding. Nature, 330, 746-748.
20. KOOB, G.F. & GOEDERS, N.E. (1989). Neuroanatomical substance of drug self-administration. In Neuropharmacological Basis of Reward. ed. Liebman, J.M. & Cooper, S.J. pp. 214-263. Oxford: Science Publishers.
21. OAKLEY, N.R., JONES, B.J., TYERS, M.B., COSTALL, B. & DOMENEY, A.M. (1988). The effect of GR 38032F on alcohol consumption in the marmoset. Br. J. Pharmacol., 95, 870P.
22. ROSSETTI, Z.L., HAMAIDAN, Y. & GESSA, G.L. (1992). Marked inhibition of mesolimbic dopamine release: a common feature of ethanol, morphine, cocaine and amphetamine abstinence in rats. Eur. J. Pharmacol., 221, 227-234.
23. 3 receptor antagonist GR 38032F decreases alcohol consumption in rats. Proc. Soc. Neurosci. 18th Ann. Meeting, Toronto, Abs. 21.4.
24. SMITH, J.E., GUERIN, C.F., CO, C., BARR, T.S. & LANE, J.D. (1985). Effects of 6-OHDA lesions of the central medial nucleus accumbens on rat intravenous morphine self-administration. Pharmacol. Biochem. Behav., 23, 843-849.
25. SPYRAKI, C., FIBIGER, H.C. & PHILIPS, A.G. (1983). Attenuation of heroin reward in rats by disruption of the mesolimbic dopamine system. Psychopharmacology, 79, 278-283.
26. ZITO, K.A., VICKERS, G. & ROBERTS, D.C.S. (1985). Disruption of cocaine and heroin self-administration following kainic acid lesions of the nucleus accumbens. Pharmacol. Biochem. Behav., 23, 1029-1306.